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Objectives: To determine if the Vibrio parahaemolyticusO3:K6 global pandemic clone has spread
into Peru.
Methods: A collection of 100 V. parahaemolyticus strains isolated from diarrhea cases in Peru
were serotyped for O:K antigens and genotyped for the presence of the species-specific toxR gene
and for the tdh and trh genes. In addition, the group-specific PCR (GS-PCR) and PCR for the
presence of the open reading frame ORF8 of the filamentous phage f237 was performed to
determine the pandemic status of the strains.
Results: Fifty strains of V. parahaemolyticus in this collection were identified as pandemic strains.
Forty-sixORF8andGS-PCRpositive strainswere identical to the global pandemic cloneO3:K6,while
four strains that also possessed the pandemic genotype and were ORF8 and GS-PCR positive
belonged to serotypes O3:K68, O3:K58 and OUT (untypable):K6. One of the O3:K6 strains was
isolated in 1996, indicating that thepandemic strainwaspresent inPeruatabout the sametime that
it caused the first outbreak in Calcutta in February 1996.
Conclusions: Based on this first report in Peru of such strains, we recommend including V. para-
haemolyticus inthedifferentialdiagnosisof theetiologicagents fordiarrheainthispartoftheworld.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.§ The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of
the Navy, Department of Defense, or the US government.
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Vibrio parahaemolyticus, a halophilic marine bacterium, is
most commonly associated with seafood-borne gastroenter-
itis. Infection results inwatery or bloody diarrheawith abdom-
inal cramps, nausea, vomiting, headache, and low-grade
fever.1 The illness is self-limiting with moderate severity in
immunocompetent individuals. The mean incubation period
for V. parahaemolyticus infection is 15 hours and ranges
between 4 and 96 hours. Although, the overall mechanism of
pathogenesis of V. parahaemolyticus is still not completely
understood, two hemolysins, namely the thermostable direct
hemolysin (Tdh) and the Tdh-related hemolysin (Trh), are
important virulence factors and play a significant role in pre-
cipitating the disease.2 Antigenic classification is based on
somatic (O) and capsular (K) antigens, and only the diar-
rhea-causing strains produce Tdh and/or Trh. Unlike Vibrio
cholerae where only two serogroups (O1 and O139) are asso-
ciated with the disease cholera, any of the more than 71
currently recognized O:K types of V. parahaemolyticus can
cause gastroenteritis.
In February 1996, however, a unique serotype — O3:K6 —
with identical genotype (tdh positive, trh and urease nega-
tive) and identical random amplified polymorphic DNA
(RAPD) profiles accounted for 50—80% of the infections
among hospitalized patients in Calcutta, India.3 In subse-
quent years, O3:K6 isolates similar to those isolated in
Calcutta were reported from food-borne outbreaks and from
sporadic cases in Bangladesh, Chile, Japan, Korea, Laos,
Mozambique, Russia, Taiwan, Thailand, and the USA. Such
a widespread occurrence of a single serotype of V. parahae-
molyticus had not previously been reported and it became
evident that a pandemic of V. parahaemolyticus gastroenter-
itis was occurring. With the recent report on the isolation of
the O3:K6 clone of V. parahaemolyticus in French coastal
waters,4 this clone has now spread into five continents,
namely Asia, North and South America, Africa, and Europe.
A novel toxRS-targeted PCR method was developed to
facilitaterapiddiagnosisof thepandemicO3:K6strains,5which
led to the serendipitous discovery of other serotypes such as
O4:K68 and O1:KUT (untypable) that had RAPD profiles, toxRS
sequences, ribotype and pulsotype identical to that of the
pandemic O3:K6 clone.5,6 These new serotypes appeared to
have diverged from the pandemic O3:K6 clone by alteration of
the O:K antigens and were postulated to be clonal derivatives
of the O3:K6 serotype.5 Multilocus sequence typing provided
strong molecular evidence for the clonal origin of pandemic V.
parahaemolyticus O3:K6 and the pandemic strains regardless
of serotype were clonal having identical allelic profiles.7 In a
collaborative study on vibrios between the Instituto de Inves-
tigacion Nutricional (IIN), Lima, Peru and the International
Centre for Diarrhoeal Diseases Research, Bangladesh (ICDDR,
B), Dhaka, Bangladesh, in collaborationwith other institutions
in Peru, we examined an archived collection of V. parahaemo-
lyticus strains from hospitalized cases of diarrhea, to deter-
mine if the pandemic clone has spread into Peru.
Materials and methods
A collection of 100 strains of V. parahaemolyticus isolated
from 1993 to 2002 from cases of hospitalized diarrhea inLima, Trujillo, and Arequipa in Peru was examined in this
study. The identity of the strains was first reconfirmed using
previously published methods.8 The strains were then ser-
otyped using a commercial V. parahaemolyticus antisera kit
produced by Denka Seiken, Tokyo, Japan. This kit contains 65
monovalent K types (K1 to K71; K2, K14, K16, K27, K35, K62
are not included), nine pooled polyvalent K groups (KI to KIX),
and 11 O groups (O1 to O11).
A PCR assay was performed to test for the presence of
the species-specific toxR gene and the strains were exam-
ined for tdh and trh using primers and procedures
described in detail previously.8 V. parahaemolyticus strain
AMVP8 (toxR+, tdh+, trh+) was used as the positive control
for all the three genes tested. In addition, to determine
the pandemic status of the strains, we performed the
group-specific PCR (GS-PCR) and PCR for determining the
presence of the open reading frame ORF8 of the filamen-
tous phage f237 as previously described.8 RAPD analysis
was done as previously described8 to examine the overall
genetic relatedness between O3:K6 strains isolated from
Peru and the reference strains of O3:K6 isolates (ATCC238
and ATCC239) and other O3:K6 pandemic strains isolated
from Bangladesh, Thailand, and Japan obtained from our
collection. A 25-ml reaction mixture containing 2.5 ml 10
PCR buffer, 2.5 ml of dNTPs mixture containing 2.5 mM
each, 4 mM MgCl2, 30 ng of chromosomal DNA, 20 pmol
of primer 1281 (50-AACGCGCAAC) and 1 U of rTaq DNA
polymerase formed the reaction mixture. PCR was per-
formed in an automated thermal cycler using the following
conditions for 45 cycles: 94 8C for 1 min, 36 8C for 2 min,
72 8C for 3 min, and a final extension of 72 8C for 7 min.
The amplified products were electrophoresed in a 1.2%
agarose gel and the gel was stained in a 0.5 mg/ml ethi-
dium bromide solution for 15 min followed by destaining
for 15 min. The gel was then visualized under UV light and
documented using the Gel Doc.Results
The 100 strains examined in this study were confirmed as V.
parahaemolyticus using conventional tests (data not shown)
and by the species-specific toxR PCR (Table 1). All strains
were tdh positive and 11 of the 100 were positive for trh.
Fifteen different serotypes were identified with O3:K6 being
the dominant. Two strains were untypable (UT) by both the O
and K types while seven strains were UT by O type and
another two were UT by K type. Forty-six strains belonging
to the O3:K6 were identified in this collection and all of them
were positive by the ORF8 and GS-PCR indicating that they
belong to the pandemic clone. Four additional strains belong-
ing to serotypes O3:K68 (1), O3:K58 (2) and OUT:K6 (1) were
also positive by the ORF8 and GS-PCR indicating that they
were also pandemic, making a total of 50 pandemic strains
(50%) identified in this collection. One of the pandemic
strains was isolated in Trujillo in 1996. Four pandemic strains
were isolated in 1997, two in Lima and two in Arequipa.
Thirty-five pandemic strains were isolated in 1998, 31 in Lima
and four in Trujillo. The ten others were isolated in the
following years: 1999 (4), 2000 (1) and 2002 (5), all in Lima.
Interestingly, prior to 1997, the non-pandemic serotype
O4:K8 dominated both in 1994 and 1996 in Trujillo.
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Table 1 Serotype, year, and location of isolation and genotype of the 100 Peruvian strains of Vibrio parahaemolyticus isolated
from hospitalized diarrhea cases
Year and location of isolation Presence of the
following genes
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 Total toxR tdh trh
Serotype T L T L T L A L T L L L L
O3:K6a 0 0 0 0 1 2 2 27 4 4 1 0 5 46 + + 
O3:K68a 0 0 0 0 0 0 0 1 0 0 0 0 0 1 + + 
O3:K58a 0 0 0 0 0 0 0 2 0 0 0 0 0 2 + + 
OUT:K6a 0 0 0 0 0 0 0 1 0 0 0 0 0 1 + + 
O2:K3 1 0 4 0 0 0 0 0 0 0 0 0 0 5 + + 
O2:KUT 0 0 1 0 0 0 0 0 0 0 0 0 0 1 + + 
O4:K8 1 2 12 0 12 0 0 1 0 0 0 0 0 28 + + 
O4:K12 0 1 0 0 0 1 0 1 0 0 1 0 0 4 + + +
O6:K18 0 0 0 0 0 0 0 0 0 0 0 1 0 1 + + +
O6:K46 0 1 0 0 0 0 0 0 0 0 0 0 0 1 + + +
O11:KUT 0 0 0 0 0 0 0 1 0 0 0 0 0 1 + + +
O11:K15 0 0 0 0 0 0 0 1 0 0 0 0 0 1 + + +
OUT:K3 0 1 0 0 0 0 0 0 0 0 0 0 0 1 + + 
OUT:K8 0 0 0 0 3 0 0 0 0 0 0 0 0 3 + + 
OUT:K46 0 0 0 2 0 0 0 0 0 0 0 0 0 2 + + +
OUT:KUT 1 0 0 0 0 0 0 0 0 0 0 0 0 1 + + 
OUT:KUT 0 0 0 0 0 0 0 0 1 0 0 0 0 1 + + +
Total 3 5 17 2 16 3 2 35 5 4 2 1 5 100
L, Lima; T, Trujillo; A, Arequipa.
a Isolates that were positive in the ORF8 and GS-PCR.The two Peruvian O3:K6 isolates of V. parahaemolyticus
showed a RAPD profile that was identical to the O3:K6
pandemic reference strains and O3:K6 pandemic isolates
from Thailand and Bangladesh and with one strain from
Japan. The RAPD profile of the other O3:K6 strain from Japan,
however, varied from the Peruvian strains and all the other
O3:K6 pandemic strains (Figure 1).
Discussion
In Peru, V. parahaemolyticus has been found in marine food
products (raw fish or seafood marinated with lemon juice,
popularly called ‘cebiche’)9 and associated with gastroen-
teritis.10 However, this is the first report on the detection of
the pandemic clone of O3:K6 from hospitalized cases and
other pandemic strains belonging to different serotypes. The
pandemic O3:K6 clone has two important attributes not seen
before among V. parahaemolyticus strains. One is their abil-
ity to rapidly elevate the incidence of infection in areas
where it enters and the other is to spread rapidly. For
example, in the Aichi Prefecture in Japan, the percentage
of outbreaks of O3:K6 V. parahaemolyticus increased from 3%
(three out of 86 outbreaks) in 1988—1995, to 75% (33 out of 44
outbreaks) in 1996—2001.11 Also, in Taiwan, the O3:K6 ser-
otype accounted for only 0.6% (three out of 526 strains) of the
V. parahaemolyticus isolated from food-borne infections in
1995; this level suddenly increased to 50.1% (372 out of 742
strains isolated) in 1996 and reached a peak of 83.8% (990 out
of 1181 strains isolated) in 1997.12
A limitation of this study is that the strains of V. para-
haemolyticus examined did not form part of a structuredsurveillance but insteadwere a collection of strains that were
saved in different laboratories. However, the high proportion
of pandemic strains identified in this collection that were
isolated in Lima in 1998 (27 from 46) revealed that an out-
break due to the pandemic clone of V. parahaemolyticus
occurred at that time in Peru.
From the literature, it seems that the first isolate that had
the pandemic trait was isolated from a traveler returning to
Japan from Indonesia in 1995.3 However, the first localized
cluster of cases of O3:K6 occurred in February 1996 in
Calcutta, indicating that the epidemiological setting in Cal-
cutta at that time was conducive to the infecting of a larger
population.3 From the archived collection of strains in Peru,
it is interesting to note that the first O3:K6 strain was found in
February 1996 in a 6-month-old baby from Trujillo, indicating
that the pandemic strain was present in Peru at about the
same time that it caused the outbreak in Calcutta in February
1996. It would be interesting to trace how the strains of V.
parahaemolyticus spread from such distant locations in Asia
to Peru; such a spread seems to be reminiscent of the spread
of the seventh pandemic strain of Vibrio cholerae O1 to the
South American continent. Retrospective analysis of data on
V. parahaemolyticus in Peru indicate that although the first
O3:K6 strain was isolated in February 1996 in Trujillo, the first
cluster of cases caused by the pandemic serotype occurred in
Lima in 1998 when 27 strains were isolated from hospitalized
cases in a short span of time in one hospital.
Chile, in South America, was particularly badly hit by this
pandemic clone in 1998 with outbreaks in the northern city of
Antofagasta from November 1997 to March 1998 and another
outbreak affecting approximately 1500 persons that occurred
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Figure 1 Random amplified polymorphic DNA (RAPD) results
for representative strains of Vibrio parahaemolyticus of serotype
O3:K6, isolated from various geographical locations. Lane 1, 1 kb
molecular size markers; lane 2, ATCC 238; lane 3, ATCC 239; lane
4, AN7410 (Bangladesh); lane 5, AO6653 (Bangladesh); lane 6,
VP5 (Thailand); lane 7, VP76 (Thailand); lane 8, ZVP6 (Japan);
lane 9, ZVP18 (Japan); lane 10, PERU 288 (Peru); lane 11, PERU
289 (Peru); lane 12, 1 kb plus molecular size markers.from January to March 2004, mainly in Puerto Mont.13 An
outbreak in early 2005 in southern and central Chile, with
more than 10 000 cases of V. parahaemolyticus infection and
one death, has recently been reported.14 Therefore, our
finding is significant because the presence of the pandemic
O3:K6 clone in Peru indicates that if the right epidemiological
and climatic conditions prevail, then the pandemic clone
could dramatically increase the number of cases of gastro-
enteritis caused by O3:K6 V. parahaemolyticus. Public health
officials should be aware and should be educated on how to
avert outbreaks and minimize the adverse impacts of out-
breaks.
Unfortunately, detection of virulent V. parahaemolyticus
in seafood or the environment against a background of
numerically greater numbers of avirulent V. parahaemolyti-
cus is a daunting problem. At this point in time, three levels
of identification that include identification as V. parahaemo-
lyticus, identification of potentially virulent V. parahaemo-
lyticus, and the identification of the pandemic clone of V.
parahaemolyticus, is required to make a clear assessment of
the potential hazard posed by this organism. Presently, only
undifferentiated total V. parahaemolyticus counts are used
as an indicator for the control of food contamination and
towards the prevention of infection. Clearly, this is inade-
quate as has been reflected in the outbreaks in the USAwhere
despite bacteriologic monitoring at harvest sites and despitethe number of V. parahaemolyticus being lower than the
permissible 10 000 most-probable-number, the outbreaks
could not be prevented.15 Therefore, for the present, should
the number of infections due to the pandemic clone begin to
show a rising trend in Lima, Trujillo or other parts of Peru,
public health officials should warn people at risk about the
hazards of the consumption of raw seafood. In the absence of
other means, this would be a proactive step to stem the
occurrence of a new outbreak and the spread of this new
emerging pathogen. Clearly, there is a need to advocate
testing for the pandemic clone in settings where the pan-
demic clone of V. parahaemolyticus has spread. There is also
a need to include V. parahaemolyticus in the differential
diagnosis of the etiologic agents for diarrhea in Peru.
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